Location · Clarkston, MI
Clinical trials in Clarkston, MI
6 recruiting studies have a site in Clarkston, and 0 of them accept healthy volunteers.
6 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 3
Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris)
Verrica Pharmaceuticals Inc.
- Location
- Clarkston, MI + 9 other US sites
- Eligibility basics
- Ages 2+
- RecruitingPhase 3
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
AbbVie
- Location
- Clarkston, MI + 29 other US sites
- Eligibility basics
- Ages 12–63
- RecruitingPhase 3
A Study to Evaluate Efficacy, Safety, and Tolerability of Remibrutinib in Adult Participants With Severe Chronic Pruritus of Unknown Origin (CPUO)
Novartis Pharmaceuticals
- Location
- Clarkston, MI + 6 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
GlaxoSmithKline
- Location
- Clarkston, MI + 36 other US sites
- Eligibility basics
- Ages 40–80
- RecruitingPhase 3
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
Eli Lilly and Company
- Location
- Clarkston, MI + 28 other US sites
- Eligibility basics
- Ages 6–17
- RecruitingPhase 3
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
GlaxoSmithKline
- Location
- Clarkston, MI + 37 other US sites
- Eligibility basics
- Ages 40–75